Cargando…

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study

Detalles Bibliográficos
Autores principales:	Thalhammer, F, Traunmüller, F, Frass, M, Hollenstein, UM, Locker, GJ, Staudinger, T, Burgmann, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301769/ http://dx.doi.org/10.1186/cc441

Ejemplares similares

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin)(®)
por: Schellongowski, P, et al.
Publicado: (2003)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Meropenem clearance by continuous haemofiltration: a comparison of in vivo and in vitro data
por: Giles, LJ, et al.
Publicado: (1999)

Outcome and prognostic factors in critically ill immunocompromised patients admitted to the ICU
por: Schellongowski, P, et al.
Publicado: (2004)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
por: Yu, Zhenwei, et al.
Publicado: (2018)

Continuous infusion versus intermittent bolus of ceftazidime for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2003)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Comparison of the Effectiveness of Prolonged Infusion and Intermittent Infusion of Meropenem in Patients With Sepsis: A Meta-Analysis
por: Lokhandwala, Adnan, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
por: Luque, Sonia, et al.
Publicado: (2021)

Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review
por: Hui, Ligia-Ancuta, et al.
Publicado: (2022)

Administration of a standardized plasma-protein solution (Biseko(®)) in high-risk patients with systemic inflammatory response syndrome: influence on cytokine levels and survival
por: Meyer, B, et al.
Publicado: (2008)

Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
por: Liebchen, Uwe, et al.
Publicado: (2021)

Therapeutic drug monitoring of meropenem and piperacilin administered in continuous infusion. preliminary data
por: Miralbés Torner, M, et al.
Publicado: (2015)

Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and Stability
por: Manning, Laurens, et al.
Publicado: (2014)

Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
por: Giles, LJ, et al.
Publicado: (1998)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
por: Zhao, Hui-Ying, et al.
Publicado: (2017)

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
por: Benítez-Cano, Adela, et al.
Publicado: (2020)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Extended Versus Intermittent Meropenem Infusion in the Treatment of Nosocomial Pneumonia: A Retrospective Single-Center Study
por: Hyun, Dong-gon, et al.
Publicado: (2023)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
por: Xu, Jinhui, et al.
Publicado: (2022)

Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
por: Smith, Susan E., et al.
Publicado: (2023)

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
por: Chytra, Ivan, et al.
Publicado: (2012)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

An investigation of the stability of meropenem in elastomeric infusion devices
por: Foy, Finbarr, et al.
Publicado: (2019)

Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison between Continuous Infusion and Intermittent Infusion
por: Taheri, Morteza, et al.
Publicado: (2018)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Tiede, Christoph, et al.
Publicado: (2021)

Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
por: Pařízková, Renata Černá, et al.
Publicado: (2021)

Continuous versus intermittent infusion of temocillin in intensive care unit patients
por: Claeysoone, K, et al.
Publicado: (2005)

Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion
por: Venugopalan, Veena, et al.
Publicado: (2018)

Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance
por: Larcher, Romaric, et al.
Publicado: (2023)

Continuous infusion versus intermittent infusion of ceftazidime for the treatment of pneumonia caused by Pseudomonas aeruginosa
por: Lorente, L, et al.
Publicado: (2005)

Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
por: Warda, Ahmed E. Abou, et al.
Publicado: (2022)

Continuous and intermittent cardiac output measurement: pulmonary artery catheter vs aortic transpulmonary technique
por: Della Rocca, G, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_l6an0rhotkiaks3s0724jm87ef